Skip to search formSkip to main contentSkip to account menu

B-Cell Lymphomas

Known as: lymphoma b-cell, cell b lymphoma, b cell lymphomas 
A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow… 
National Institutes of Health

Related topics

Related topics

37 relations
50 ML rituximab 10 MG/ML InjectionAtypical lymphocyteB-LymphocytesBMI1 gene

Narrower (1)

Burkitt Lymphoma

Broader (1)

Lymphoma, Non-Hodgkin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma
Background In a phase 1 trial, axicabtagene ciloleucel (axi‐cel), an autologous anti‐CD19 chimeric antigen receptor (CAR) T‐cell… 
Highly Cited
2008
Highly Cited
2008
Stromal gene signatures in large-B-cell lymphomas.
BACKGROUND The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone… 
Review
2005
Review
2005
WHO-EORTC classification for cutaneous lymphomas.
Primary cutaneous lymphomas are currently classified by the European Organization for Research and Treatment of Cancer (EORTC… 
Highly Cited
2005
Highly Cited
2005
Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
We show that the microRNA miR-155 can be processed from sequences present in BIC RNA, a spliced and polyadenylated but non… 
Highly Cited
2004
Highly Cited
2004
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important subgroups with germinal center B-cell-like… 
Highly Cited
2002
Highly Cited
2002
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… 
Highly Cited
2002
Highly Cited
2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
BACKGROUND The survival of patients with diffuse large-B-cell lymphoma after chemotherapy is influenced by molecular features of… 
Highly Cited
2002
Highly Cited
2002
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is curable in less than 50% of patients… 
Highly Cited
2002
Highly Cited
2002
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
BACKGROUND The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… 
Highly Cited
2000
Highly Cited
2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License